Clinical Trials Logo

Apnea clinical trials

View clinical trials related to Apnea.

Filter by:

NCT ID: NCT02591979 Completed - Clinical trials for Sleep Apnea Syndrome

PASHOS Project: Advanced Platform for Sleep Apnea Syndrome Assessment

Start date: March 2015
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to develop and validate a work-model in Primary Health Care for identifying patients with Sleep Apnea Syndrome, based on clinical variables and an ambulatory monitoring study.

NCT ID: NCT02588469 Completed - Clinical trials for Sleep Apnea, Obstructive

Exercise and Venous Compression on Upper Airway Resistance in Obese Teenagers With OSA

OBESOMAC
Start date: August 27, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of physical exercise, associated or not with venous compression of the leg, on obstructive sleep apnea (OSA) severity and upper airway resistance in obese teenagers. Half of the participants will undergo physical exercise and compression socks program, and the other half of subjects will undergo physical exercise program without compression socks.

NCT ID: NCT02580526 Completed - Apnea Clinical Trials

Comparison of Mask Ventilation Techniques in Patients Requiring General Anesthesia

Start date: September 2015
Phase: N/A
Study type: Interventional

This study compares the effectiveness of two kinds of two-handed facemask ventilation techniques (when breathing is supported with machines) at the time that general anesthesia is started. Study participants will start with one technique and then cross over to the other technique.

NCT ID: NCT02576587 Completed - Atrial Fibrillation Clinical Trials

Influence of Sleep Apnea on Risk of Atrial Fibrillation

Safebeat
Start date: January 1, 2012
Phase: N/A
Study type: Interventional

The Elucidation of the Influence of Sleep Apnea on Risk of Atrial Fibrillation study. The study involves a case control design to investigate the extent to which there is an independent relationship of sleep disordered breathing (SDB) and paroxysmal atrial fibrillation (PAF). Cases will be defined as clinically identified patients with PAF and controls as those without AF. In order to rigorously address important biologic confounding influences, the cases and controls will be individually matched based upon age, gender, race, and body mass index. Those participants with both PAF and SDB (Apnea Hypopnea Index, AHI>=15) will be asked to return for a follow up exam after 3 months of SDB treatment in the Clinical Research Unit (CRU) for collection of the same measures collected at the baseline exam to observe for any significant changes with the purpose of collecting effect size data to inform future clinical trials. The total duration of the study is 4 years. The duration for any individual participant is up to from one to 13 weeks months, including a 3-month treatment period for those with moderate to severe SDB, i.e. AHI>15.

NCT ID: NCT02566226 Completed - Clinical trials for Sleep Apnea Syndromes

Impact of Intrathecal Morphine on Sleep Apnea Syndrome

Start date: November 2015
Phase: Phase 4
Study type: Interventional

Intrathecal morphine is commonly used as an analgesic adjunct for hip arthroplasty performed under spinal anaesthesia. Sleep apnea syndrome is a condition that affects up to 10% of the patients. Effect of intrathecal hydrophilic opioids on the frequency and duration of apneic episodes is unknown. The objective of this randomised controlled trial is to investigate the effect of intrathecal morphine and surgery on apneic episodes.

NCT ID: NCT02564068 Completed - Sleep Apnea Clinical Trials

Oxytocin on HR in Sleep Apnea Patient

Start date: May 22, 2015
Phase: Early Phase 1
Study type: Interventional

In human volunteers intranasal administration of oxytocin significantly increases parasympathetic and decreases sympathetic cardiac control. OSA is a very prevalent disease with high cardiovascular risk factors, yet this disease remains very poorly treated. This proposal, based on the current literature and new basic science results detailed above on the role of oxytocin in cardiovascular control, will test if oxytocin administration improves adverse cardiovascular events during the recurrent nocturnal apneas in patients with OSA. This project will lay the groundwork and provide preliminary data to obtain NIH funding to test this important hypotheses more thoroughly and in larger clinical trials. This study will explore if intranasal oxytocin has any positive cardiovascular benefits in patients with sleep apnea.

NCT ID: NCT02554110 Completed - Hypoxemia Clinical Trials

Peripheral Nerve Stimulation to Reduce Hypoxic Events

Start date: October 12, 2015
Phase: N/A
Study type: Interventional

This study is designed to determine if using peripheral nerve stimulation in conjunction with pulse oximetry as an adjunct to traditional monitoring in the PACU reduces the frequency and severity of sedation related apnea and hypoxic events.

NCT ID: NCT02553694 Completed - Clinical trials for Obstructive Sleep Apnea

Sleep Apnea Video Education for CPAP (SAVE-CPAP)

SAVE-CPAP
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine how satisfied patients are when undergoing an overnight polysomnogram (sleep study), what their knowledge about sleep apnea is, and what factors affect obstructive sleep apnea (OSA) treatment use.

NCT ID: NCT02542488 Completed - Pregnancy Clinical Trials

STOPBANG As A Screening Tool for Obstructive Sleep Apnoea in Pregnancy

Start date: February 2, 2016
Phase:
Study type: Observational

This study evaluates the use of the STOPBANG questionnaire to predict whether a pregnant woman with class III obesity has obstructive sleep apnoea. All participants will have a STOPBANG score and modified STOPBANG score (substituting Epworth score > 10 with the tired item) calculated and then be tested with overnight pulse oximetry to see if they meet ODI criteria for obstructive sleep apnoea.

NCT ID: NCT02540603 Completed - Clinical trials for Obstructive Sleep Apnea

Evaluation of a Full Face Mask for the Treatment of Obstructive Sleep Apnea (OSA) in NZ

Start date: September 2015
Phase: N/A
Study type: Interventional

This investigation is designed to evaluate the performance (leak and comfort) as well as participant's overall acceptance of the investigative full face mask amongst OSA participants.